ArticleFrontiers in oncology2024

Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.

Liujing Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.